Evidence map›Paper›PMID 30858608›Full record

ArticleCell death and differentiation2019

Brf1 loss and not overexpression disrupts tissues homeostasis in the intestine, liver and pancreas.

Dritan Liko, Louise Mitchell, Kirsteen J Campbell, Rachel A Ridgway, Carolyn Jones, Kate Dudek, Ayala King, Sheila Bryson, David Stevenson, Karen Blyth and 6 more

Erratum issuedOpen access · hybridAbstract read
In one paragraph

Article in Cell death and differentiation, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. RNA Polymerases I and III in development and disease.Seminars in cell & developmental biology · 2023
    Review
  6. Defective myelination in an RNA polymerase III mutant leukodystrophic mouse.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  7. Review
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 2 institutions in 1 country.

Dritan Liko *CRUK Beatson Institute, Garscube Estate, Switchback Road, Glasgow, G61 1BD, UK.
Louise Mitchell *CRUK Beatson Institute, Garscube Estate, Switchback Road, Glasgow, G61 1BD, UK.
Kirsteen J CampbellCRUK Beatson Institute, Garscube Estate, Switchback Road, Glasgow, G61 1BD, UK.ORCID http://orcid.org/0000-0002-0201-8736
Rachel A RidgwayCRUK Beatson Institute, Garscube Estate, Switchback Road, Glasgow, G61 1BD, UK.
Carolyn JonesMRC Toxicology Unit, Hodgkin Building Lancaster Road, Leicester, LE1 9HN, UK.
Kate DudekMRC Toxicology Unit, Hodgkin Building Lancaster Road, Leicester, LE1 9HN, UK.
Ayala KingCRUK Beatson Institute, Garscube Estate, Switchback Road, Glasgow, G61 1BD, UK.
Sheila BrysonCRUK Beatson Institute, Garscube Estate, Switchback Road, Glasgow, G61 1BD, UK.
David StevensonCRUK Beatson Institute, Garscube Estate, Switchback Road, Glasgow, G61 1BD, UK.
Karen BlythCRUK Beatson Institute, Garscube Estate, Switchback Road, Glasgow, G61 1BD, UK.ORCID http://orcid.org/0000-0002-9304-439X
Douglas StrathdeeCRUK Beatson Institute, Garscube Estate, Switchback Road, Glasgow, G61 1BD, UK.ORCID http://orcid.org/0000-0003-2959-4327
Jennifer P MortonCRUK Beatson Institute, Garscube Estate, Switchback Road, Glasgow, G61 1BD, UK.
Thomas G BirdCRUK Beatson Institute, Garscube Estate, Switchback Road, Glasgow, G61 1BD, UK.ORCID http://orcid.org/0000-0002-6120-1581
John R P KnightCRUK Beatson Institute, Garscube Estate, Switchback Road, Glasgow, G61 1BD, UK. j.knight@beatson.gla.ac.uk.ORCID http://orcid.org/0000-0002-8771-5484
Anne E WillisMRC Toxicology Unit, Hodgkin Building Lancaster Road, Leicester, LE1 9HN, UK.
Owen J SansomCRUK Beatson Institute, Garscube Estate, Switchback Road, Glasgow, G61 1BD, UK. o.sansom@beatson.gla.ac.uk.ORCID http://orcid.org/0000-0001-9540-3010
Cancer Research UK Scotland Institute · GBMRC Toxicology Unit · GB

Funding

Cancer Research UK 21139Cancer Research UK 26813Cancer Research UK 29799Cancer Research UK 29996Cancer Research UK A10419Cancer Research UK A11650Cancer Research UK A12481Cancer Research UK A21139European Research Council 311301Medical Research Council MC_UP_A600_1023Medical Research Council MC_UU_00025/7Wellcome Trust 107492
6 · The paper itself

Abstract

RNA polymerase III (Pol-III) transcribes tRNAs and other small RNAs essential for protein synthesis and cell growth. Pol-III is deregulated during carcinogenesis; however, its role in vivo has not been studied. To address this issue, we manipulated levels of Brf1, a Pol-III transcription factor that is essential for recruitment of Pol-III holoenzyme at tRNA genes in vivo. Knockout of Brf1 led to embryonic lethality at blastocyst stage. In contrast, heterozygous Brf1 mice were viable, fertile and of a normal size. Conditional deletion of Brf1 in gastrointestinal epithelial tissues, intestine, liver and pancreas, was incompatible with organ homeostasis. Deletion of Brf1 in adult intestine and liver induced apoptosis. However, Brf1 heterozygosity neither had gross effects in these epithelia nor did it modify tumorigenesis in the intestine or pancreas. Overexpression of BRF1 rescued the phenotypes of Brf1 deletion in intestine and liver but was unable to initiate tumorigenesis. Thus, Brf1 and Pol-III activity are absolutely essential for normal homeostasis during development and in adult epithelia. However, Brf1 overexpression or heterozygosity are unable to modify tumorigenesis, suggesting a permissive, but not driving role for Brf1 in the development of epithelial cancers of the pancreas and gut.

Indexed as

AnimalsButyrate Response Factor 1HomeostasisHumansIntestinal MucosaLiverMicePancreasTATA-Binding Protein Associated FactorsBRF1 protein, humanButyrate Response Factor 1TATA-Binding Protein Associated FactorsZfp36l1 protein, mouse

Identifiers

PMID30858608
PMCPMC6861133
OpenAlexW2922090145

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.